Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 16 October 2020
Accepted: 5 November 2020
First Online: 9 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: LQ received honoraria and unrestricted research grants from Boehringer-Ingelheim, France, UCB Pharma, Belgium, and Abbott International, Il, USA [1986–1996], and holds US patent 8 846 606 B2, September 30, 2014 (method and drug composition for treating septic shock hypotension).
